Advance in Development of Patient-Centric Dosage Form, 3rd Edition

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".

Deadline for manuscript submissions: 20 December 2024 | Viewed by 261

Special Issue Editors

E-Mail Website
Guest Editor
School of Pharmacy, Queen's University Belfast, Belfast BT7 1NN, UK
Interests: 3D printing; bioprinting; drug delivery; electrospinning; medical devices; pharmaceutics; microfluidics
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Fondazione Ri. MED, 90133 Palermo, PA, Italy
Interests: medicine acceptability; patient-centric formulation; sustained release dosage form; solid dosage form
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is established that the medication acceptability of dosage forms could influence patient compliance and treatment efficacy and safety. Currently, research focuses on developing patient-centric formulations as personalized dosage forms that provide benefits for individual patient needs. According to the World Health Organization (WHO), patient-centric formulations are becoming essential for public health when dealing with long-term diseases treated with multiple drugs. However, data related to the understanding of dosage-form-related issues in medication acceptability are lacking. Therefore, the development of advanced technologies has resulted in significant efforts to develop customizable dosage forms.

Given that the first and second volumes of this Special Issue have received widespread scholarly attention, we hereby open its third volume. The focus of this Special Issue of Pharmaceutics will be on assessing and identifying dosage-form-related issues in medication acceptability and recent advances in the development of effective strategies to produce patient-centric dosage forms to address these problems. This Special Issue will accept both reviews and research articles.

Prof. Dr. Dimitrios A. Lamprou
Dr. Laura Modica de Mohac
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • medication acceptability
  • patient-centric dosage forms
  • solid dosage forms
  • assessment
  • advances
  • technology
  • product customization

Published Papers

This special issue is now open for submission.
Back to TopTop